CLASS I Drug recall · Reported 6 Jul 2022 · FDA Enforcement Report
SnoreStop NasoSpray, Green Pharmaceuticals Inc. Camarillo, CA recalled
Green Pharmaceuticals is recalling SnoreStop NasoSpray, Green Pharmaceuticals Inc. Camarillo, CA 93012, distributed nationwide in the US. The recall was initiated on 9 Jun 2022 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1165-2022
- FDA event ID
- 90384
- Recalling firm
- Green Pharmaceuticals, Camarillo, CA
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 9 Jun 2022
- FDA classified
- 27 Jun 2022
- Reported
- 6 Jul 2022
- Type
- Voluntary: Firm initiated
- Customers notified by
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Reason category
- Sterility
Timeline
| 9 Jun 2022 | Recall initiated by company | |
| 27 Jun 2022 | Classified by FDA | +18 days |
| 6 Jul 2022 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
SnoreStop NasoSpray, 0.3 FL OZ (9 mL), Green Pharmaceuticals Inc. Camarillo, CA 93012, NDC 61152-199-99, UPC 7 69682 29101 3
Where it was distributed
Nationwide within the United States
Questions about this recall
Is SnoreStop NasoSpray, Green Pharmaceuticals Inc. Camarillo, CA 93012 recalled?
Yes. Green Pharmaceuticals recalled SnoreStop NasoSpray, Green Pharmaceuticals Inc. Camarillo, CA 93012 on 9 Jun 2022. The recall is Class I and its status is Terminated. Recall number D-1165-2022.
Why was it recalled?
Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.
Which lots are affected?
Lot #: 2373/21222
Where was it sold?
Nationwide within the United States
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.